Healthcare & Medical Investment (TSE:3455) Long-Term Debt: 円38,700 Mil (As of Jan. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:3455 Healthcare & Medical Investment Corp TSE:3455
59 GF Score
Price 円105,400.00
GF Value 円129,254.71
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Healthcare & Medical Investment Long-Term Debt?

Healthcare & Medical Investment TSE:3455 -2.04% 59 Long-Term Debt is 円38,700 Mil as of Jan. 2026. GuruFocus rates TSE:3455 with a GF Score™ of 59/100 and a GF Value™ of 円129,254.71 (Modestly Undervalued). The stock has 4 warning signs investors should review.

Healthcare & Medical Investment's Long-Term Debt for the quarter that ended in Jan. 2026 was 円38,700 Mil.

Healthcare & Medical Investment's quarterly Long-Term Debt stayed the same from Jan. 2025 (円35,250 Mil) to Jul. 2025 (円35,250 Mil) but then increased from Jul. 2025 (円35,250 Mil) to Jan. 2026 (円38,700 Mil).

Healthcare & Medical Investment's annual Long-Term Debt increased from Jul. 2023 (円29,900 Mil) to Jul. 2024 (円36,100 Mil) but then declined from Jul. 2024 (円36,100 Mil) to Jul. 2025 (円35,250 Mil).

Healthcare & Medical Investment  (TSE:3455) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Healthcare & Medical Investment Long-Term Debt Related Terms

Healthcare & Medical Investment Long-Term Debt Historical Data

* Premium members only.

The historical data trend for Healthcare & Medical Investment's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Healthcare & Medical Investment Long-Term Debt Chart

Healthcare & Medical Investment Annual Data
Trend Jul16 Jul17 Jul18 Jul19 Jul20 Jul21 Jul22 Jul23 Jul24 Jul25
Long-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 26,150.00 27,400.00 29,900.00 36,100.00 35,250.00

Healthcare & Medical Investment Semi-Annual Data
Jul16 Jan17 Jul17 Jan18 Jul18 Jan19 Jul19 Jan20 Jul20 Jan21 Jul21 Jan22 Jul22 Jan23 Jul23 Jan24 Jul24 Jan25 Jul25 Jan26
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 31,600.00 36,100.00 35,250.00 35,250.00 38,700.00
TSE:3455
59GF Score
Healthcare & Medical Investment Corp TSE:3455
Long-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Long-Term Debt →
What does a Long-Term Debt of 円38,700 Mil mean?
Healthcare & Medical Investment (TSE:3455) has a Long-Term Debt of 円38,700 Mil as of Jan. 2026.
Is Healthcare & Medical Investment's Long-Term Debt too high?
Healthcare & Medical Investment's current Long-Term Debt is 円38,700 Mil. Overall, Healthcare & Medical Investment has a GF Score™ of 59/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Healthcare & Medical Investment's Long-Term Debt compare to WELL and VTR?
Healthcare & Medical Investment's Long-Term Debt of 円38,700 Mil can be compared against companies in the REITs industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Long-Term Debt for a REITs company?
A good Long-Term Debt depends on the REITs industry context. However, Long-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Long-Term Debt mean?
A high Long-Term Debt can signal that a stock is expensive relative to its fundamentals. Healthcare & Medical Investment's current Long-Term Debt is 円38,700 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Healthcare & Medical Investment stock overvalued right now?
Based on GuruFocus' analysis, Healthcare & Medical Investment (TSE:3455) is currently considered Modestly Undervalued. The stock's GF Value™ is 円129,254.71, compared to a current price of 円105,400.00 — trading 18.5% below its estimated fair value. The current Long-Term Debt is 円38,700 Mil. Healthcare & Medical Investment's overall GF Score™ is 59/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Long-Term Debt calculated?
Long-Term Debt is calculated from a company's financial statements. For Healthcare & Medical Investment (TSE:3455), the current Long-Term Debt is 円38,700 Mil as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Healthcare & Medical Investment (TSE:3455) Overvalued in 2026?

Based on GuruFocus' analysis, Healthcare & Medical Investment stock appears to be undervalued. The current stock price of 円105,400.00 is trading 18.5% below its estimated GF Value™ of 円129,254.71. GuruFocus considers Healthcare & Medical Investment to be Modestly Undervalued.

Key valuation signals for TSE:3455:

  • Long-Term Debt: 円38,700 Mil
  • GF Value™: 円129,254.71 vs. price of 円105,400.00 (18.5% below fair value)
  • GF Score™: 59/100 with 4 warning signs

No single metric tells the full story. See the TSE:3455 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Healthcare & Medical Investment Business Description

Industry Real EstateREITs
Address 3-3, Kanda-ogawamachi, Chiyoda-ku, Tokyo, JPN
Healthcare & Medical Investment Corp is an investment company, which invests in nursing homes facilities and medical related real properties. The company aims to achieve stable earnings from mid- to long-term perspectives through investment in real estate and other related assets. The firm primarily invests in facilities and buildings for the elderly, as well as medical related facilities.
59GF Score

Get the complete analysis for TSE:3455

Long-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円105,400.00
Price
円129,254.71
GF Value